肥厚型心肌病和肌节突变患者心脏中差异产生的微小RNA概况。 - Suppr

Suppr

超能文献

Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations.

作者信息

Palacín María, Reguero Julián R, Martín María, Díaz Molina Beatriz, Morís César, Alvarez Victoria, Coto Eliecer

出版信息

Clin Chem. 2011 Nov;57(11):1614-6. doi: 10.1373/clinchem.2011.168005. Epub 2011 Sep 2.

DOI:10.1373/clinchem.2011.168005

PMID:21890708

Abstract

摘要

相似文献

Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations.肥厚型心肌病和肌节突变患者心脏中差异产生的微小RNA概况。

Clin Chem. 2011 Nov;57(11):1614-6. doi: 10.1373/clinchem.2011.168005. Epub 2011 Sep 2.

Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.家族性肥厚型心肌病：肌球蛋白突变 R723G 在心肌细胞中的功能影响。

J Mol Cell Cardiol. 2013 Apr;57:13-22. doi: 10.1016/j.yjmcc.2013.01.001. Epub 2013 Jan 11.

A p.R870H mutation in the beta-cardiac myosin heavy chain 7 gene causes familial hypertrophic cardiomyopathy in several members of an Indian family.β-心肌肌球蛋白重链7基因中的p.R870H突变在一个印度家庭的几名成员中导致家族性肥厚型心肌病。

Can J Cardiol. 2007 Aug;23(10):788-90. doi: 10.1016/s0828-282x(07)70828-0.

Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.肌节基因的细肌丝（TPM1）和粗肌丝（MYH7）中双基因突存共存导致一名南印度家族性肥厚型心肌病患者出现严重肥厚型心肌病。

DNA Cell Biol. 2015 May;34(5):350-9. doi: 10.1089/dna.2014.2650. Epub 2015 Jan 21.

A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.一个多态性修饰基因改变了家族性肥厚型心肌病小鼠模型中的肥厚反应。

J Mol Cell Cardiol. 2001 Nov;33(11):2055-60. doi: 10.1006/jmcc.2001.1466.

Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy.MYH7 基因突变降低了人类家族性肥厚型心肌病中肌节的产生力。

Cardiovasc Res. 2013 Aug 1;99(3):432-41. doi: 10.1093/cvr/cvt119. Epub 2013 May 13.

A new missense mutation, p.Arg719Leu, of the beta-myosin heavy chain gene in a patient with familial hypertrophic cardiomyopathy.一名家族性肥厚型心肌病患者的β-肌球蛋白重链基因出现新的错义突变，即p.Arg719Leu。

Minerva Cardioangiol. 2017 Feb;65(1):96-102. doi: 10.23736/S0026-4725.16.04208-0.

A novel MYH7 mutation in a family with cardiomyopathy presenting with restrictive physiology and varying degrees of left ventricle hypertrophy.一个患有心肌病的家族中存在一种新型MYH7突变，该家族表现为限制性生理学特征和不同程度的左心室肥厚。

Eur Heart J. 2015 Jan 14;36(3):178. doi: 10.1093/eurheartj/ehu435. Epub 2014 Nov 24.

Mutation-specific pathology and treatment of hypertrophic cardiomyopathy in patients, mouse models and human engineered heart tissue.特定突变的肥厚型心肌病患者、小鼠模型和人源工程心脏组织的病理学特征和治疗方法。

Biochim Biophys Acta Mol Basis Dis. 2020 Aug 1;1866(8):165774. doi: 10.1016/j.bbadis.2020.165774. Epub 2020 Mar 23.

The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.导致家族性肥厚型心肌病的肌球蛋白轻链（RLC）的E22K突变会增加转基因小鼠中力和ATP酶的钙敏感性。

J Cell Sci. 2005 Aug 15;118(Pt 16):3675-83. doi: 10.1242/jcs.02492. Epub 2005 Aug 2.

引用本文的文献

Identification of novel genetic variants associated with feline cardiomyopathy using targeted next-generation sequencing.使用靶向新一代测序技术鉴定与猫心肌病相关的新型基因变异体。

Sci Rep. 2025 Jan 31;15(1):3871. doi: 10.1038/s41598-025-87852-5.

MicroRNA profiling of the feline left heart identifies chamber-specific expression signatures in health and in advanced hypertrophic cardiomyopathy.猫左心的微小RNA分析确定了健康和晚期肥厚型心肌病中特定腔室的表达特征。

J Mol Cell Cardiol Plus. 2023 Jun 2;4:100037. doi: 10.1016/j.jmccpl.2023.100037. eCollection 2023 Jun.

Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research?循环微小RNA作为肥厚型心肌病中有前景的生物标志物：先进的心脏磁共振能否为研究带来新见解？

Exp Biol Med (Maywood). 2024 Dec 18;249:10334. doi: 10.3389/ebm.2024.10334. eCollection 2024.

Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways.全面转录组学 miRNA 分析揭示肥厚型心肌病的血浆循环生物标志物和失调的信号通路。

Circ Heart Fail. 2023 Jun;16(6):e010010. doi: 10.1161/CIRCHEARTFAILURE.122.010010. Epub 2023 Jun 12.

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers.肥厚型心肌病中的微小RNA：发病机制、诊断、治疗潜力及作为临床生物标志物的作用

Heart Fail Rev. 2022 Nov;27(6):2211-2221. doi: 10.1007/s10741-022-10231-z. Epub 2022 Mar 25.

miR-208a in Cardiac Hypertrophy and Remodeling.心肌肥厚与重塑中的miR-208a

Front Cardiovasc Med. 2021 Dec 9;8:773314. doi: 10.3389/fcvm.2021.773314. eCollection 2021.

A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy.一种新的 miRNA 筛选方法确定 miRNA-4454 是肥厚型心肌病患者心室纤维化的候选生物标志物。

Biomolecules. 2021 Nov 18;11(11):1718. doi: 10.3390/biom11111718.

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy.肥厚型、致心律失常型和扩张型心肌病中的微小RNA

Diagnostics (Basel). 2021 Sep 19;11(9):1720. doi: 10.3390/diagnostics11091720.

MicroRNAs as Biomarkers of Systemic Changes in Response to Endurance Exercise-A Comprehensive Review.作为耐力运动反应中全身变化生物标志物的微小RNA——一篇综述

Diagnostics (Basel). 2020 Oct 13;10(10):813. doi: 10.3390/diagnostics10100813.

miR-25 Promotes Cardiomyocyte Proliferation by Targeting FBXW7.微小RNA-25通过靶向F-box蛋白7促进心肌细胞增殖。

Mol Ther Nucleic Acids. 2020 Mar 6;19:1299-1308. doi: 10.1016/j.omtn.2020.01.013. Epub 2020 Jan 21.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验